Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 3 Results

  1. 1

    Sexually transmitted diseases research needs: report of a WHO consultative group, Copenhagen, 13-14 September 1989.

    World Health Organization [WHO]. Programme for Sexually Transmitted Diseases

    [Unpublished] 1991. Presented at the 1st International Course on Planning and Managing STD Control Activities in Developing Countries, Antwerp, Belgium, September 9-21, 1991. 31 p.

    In response to the growing needs for research into sexually transmitted diseases (STDs), the STD Program of the World Health Organization (WHO) in September 1989 convened a small interdisciplinary consultative group of scientists from both developing and more developed countries to review STD research priorities. The consultation was organized based upon the belief that a joint consideration of global STD research priorities and local research capabilities would increase overall research capacity by coordinating the efforts of scientists from around the world to get the job done. Participants considered the areas of biomedical research, clinical and epidemiological research, behavioral research, and operations research. However, research needs directly related to HIV were not considered except where they interfaced with research on other STDs. The above areas of research, as well as the expansion of interregional and interdisciplinary collaborations, the strengthening of research institutions, developing and strengthening research training, and facilitating technology transfer and the use of marketing systems are discussed.
    Add to my documents.
  2. 2

    The Integration of Population Variables into the Socio-Economic Planning Process. An International Seminar jointly sponsored by the UN Population Division, UNFPA and CICRED, and hosted by the Government of Morocco, Rabat, Morocco, 9-12 March 1987. Integration des Variables Demographiques dans le Processus de Planification Economique et Sociale. Seminaire International organise sous le patronage conjoint de la Division de la Population des Nations Unies, du FNUAP et du CICRED, et tenu a Rabat a l'invitation du Gouvernement du Maroc, Rabat, Maroc, 9-12 mars 1987.

    United Nations. Department of International Economic and Social Affairs. Population Division; United Nations Fund for Population Activities [UNFPA]

    Paris, France, CICRED, 1988. 159 p.

    Conference proceedings from an international seminar sponsored by the UN Population Division, the UN Fund for Population Activities (UNFPA), and the Committee for International Cooperation in National Research in Demography (CICRED) are presented in both French and english versions in one volume. Hosted by the government of Morocco, the opening speech is delivered by the Secretary General of the Ministry of Planning of Morocco. The statement from the UNFPA is then presented, followed by a message from the Director of the UN Population Division. The Coordinator of the Project next provides the foreword. Report of the Seminar is made, including annexes of the agenda and list of participating institutions, followed by discussion of possible areas of research and application. Research projects currently implemented or contemplated by participating centers are listed, with closing comments from the Vice-President and Bureau of CICRED. A list of documents prepared by the participants is included.
    Add to my documents.
  3. 3

    Role of the pharmaceutical industry of the developing countries in research on fertility regulation.

    Anand N; Kamboj VP

    In: Diczfalusy E, Diczfalusy A, ed. Research on the regulation of human fertility: needs of developing countries and priorities for the future, Vol. 2. Background documents. Copenhagen, Denmark, Scriptor, 1983. 975-86.

    The pharmaceutical industry of the developing countries is at present not equipped for and unlikely to contribute much to the discovery and development of new fertility regulating agents, but could play an effective role in process development, and in the organization of clinical trials. In view of the crucial role of the pharmaceutical industry to bring the research effort on a new contraceptive to fruition, and because of the waning interest of the industries of the developed countries in this field, the pharmaceutical companies of the developing countries should be encouraged to get involved in research by special incentives from their national governments, such as tax exemption for investment made for inhouse research of for sponsored research. The subsidiaries of multinational corporations, which dominate the pharmaceutical industry in the developing world, must establish research centers in these countries with efforts focussed on local priority health problems, such as contraceptive development; such research conducted in some of the developing countries would be more cost effective. It would be necessary to establish government or public sector research institutes to supplement the research facilities of the private industries, particularly for animal toxicology studies; these institutions could even serve as regional centers, supported by international agencies, since some of the smaller countries may not be able to develop their own centers. The collaboration between industrial, academic and public secotr institutions should be encouraged and formalized to establish partnership in research on contraceptive development; the exact mode and form would depend upon the scientific and technical institutional structure and industrial development status of each country. (author's modified)
    Add to my documents.